BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BL. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J. 2008;29:1147-1159. [PMID: 18349024 DOI: 10.1093/eurheartj/ehn113] [Cited by in Crossref: 209] [Cited by in F6Publishing: 143] [Article Influence: 14.9] [Reference Citation Analysis]
Number Citing Articles
1 Sogbein OO, Pelletier-Galarneau M, Schindler TH, Wei L, Wells RG, Ruddy TD. New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease. Biomed Res Int 2014;2014:942960. [PMID: 24901002 DOI: 10.1155/2014/942960] [Cited by in Crossref: 35] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
2 Pontico M, Brunotti G, Conte M, Corica F, Cosma L, De Angelis C, De Feo MS, Lazri J, Matto A, Montebello M, Di Rocco A, Frantellizzi V, Farcomeni A, De Vincentis G. The prognostic value of 123I-mIBG SPECT cardiac imaging in heart failure patients: a systematic review. J Nucl Cardiol 2021. [PMID: 33442819 DOI: 10.1007/s12350-020-02501-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Russell RR, Alexander J, Jain D, Poornima IG, Srivastava AV, Storozynsky E, Schwartz RG. The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy. J Nucl Cardiol 2016;23:856-84. [DOI: 10.1007/s12350-016-0538-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
4 Tsutamoto T, Nishiyama K, Sakai H, Tanaka T, Fujii M, Yamamoto T, Yamaji M, Horie M. Transcardiac increase in norepinephrine and prognosis in patients with chronic heart failure. European Journal of Heart Failure 2008;10:1208-14. [DOI: 10.1016/j.ejheart.2008.09.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
5 Nakae I, Hayashi H, Mitsunami K, Horie M. Clinical significance of lung iodine-123 metaiodobenzylguanidine uptake assessment in Parkinson’s and heart diseases. Ann Nucl Med 2013;27:737-47. [DOI: 10.1007/s12149-013-0741-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
6 Kuwabara Y, Tamaki N, Nakata T, Yamashina S, Yamazaki J. Determination of the survival rate in patients with congestive heart failure stratified by ¹²³I-MIBG imaging: a meta-analysis from the studies performed in Japan. Ann Nucl Med. 2011;25:101-107. [PMID: 21210256 DOI: 10.1007/s12149-010-0452-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
7 De Vincentis G, Frantellizzi V, Fedele F, Farcomeni A, Scarparo P, Salvi N, Fegatelli DA, Mancone M, Verschure DO, Verberne HJ. Role of cardiac 123I-mIBG imaging in predicting arrhythmic events in stable chronic heart failure patients with an ICD. J Nucl Cardiol 2019;26:1188-96. [PMID: 29594915 DOI: 10.1007/s12350-018-1258-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
8 Bonsu KO, Reidpath DD, Kadirvelu A. Lipophilic Statin Versus Rosuvastatin (Hydrophilic) Treatment for Heart Failure: a Meta-Analysis and Adjusted Indirect Comparison of Randomised Trials. Cardiovasc Drugs Ther 2016;30:177-88. [PMID: 26780905 DOI: 10.1007/s10557-015-6636-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
9 Nuvoli S, Spanu A, Fravolini ML, Bianconi F, Cascianelli S, Madeddu G, Palumbo B. [123I]Metaiodobenzylguanidine (MIBG) Cardiac Scintigraphy and Automated Classification Techniques in Parkinsonian Disorders. Mol Imaging Biol 2020;22:703-10. [PMID: 31309370 DOI: 10.1007/s11307-019-01406-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
10 Kobayashi R, Chen X, Werner RA, Lapa C, Javadi MS, Higuchi T. New horizons in cardiac innervation imaging: introduction of novel 18F-labeled PET tracers. Eur J Nucl Med Mol Imaging 2017;44:2302-9. [DOI: 10.1007/s00259-017-3828-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
11 Chen X, Werner RA, Javadi MS, Maya Y, Decker M, Lapa C, Herrmann K, Higuchi T. Radionuclide imaging of neurohormonal system of the heart. Theranostics 2015;5:545-58. [PMID: 25825596 DOI: 10.7150/thno.10900] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
12 Valensi P. Autonomic nervous system activity changes in patients with hypertension and overweight: role and therapeutic implications. Cardiovasc Diabetol 2021;20:170. [PMID: 34412646 DOI: 10.1186/s12933-021-01356-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
13 Verschure DO, Veltman CE, Manrique A, Somsen GA, Koutelou M, Katsikis A, Agostini D, Gerson MC, van Eck-smit BLF, Scholte AJHA, Jacobson AF, Verberne HJ. For what endpoint does myocardial 123I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis. European Heart Journal - Cardiovascular Imaging 2014;15:996-1003. [DOI: 10.1093/ehjci/jeu044] [Cited by in Crossref: 66] [Cited by in F6Publishing: 39] [Article Influence: 8.3] [Reference Citation Analysis]
14 van der Veen L, Scholte A, Stokkel M. Mathematical methods to determine quantitative parameters of myocardial 123I-MIBG studies: a review of the literature. Nucl Med Commun 2010;31:617-28. [PMID: 20220545 DOI: 10.1097/MNM.0b013e328337a99b] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
15 Seo M, Yamada T, Tamaki S, Watanabe T, Morita T, Furukawa Y, Kawasaki M, Kikuchi A, Kawai T, Abe M, Nakamura J, Yamamoto K, Kayama K, Kawahira M, Tanabe K, Kimura T, Ueda K, Sakamoto D, Sakata Y, Fukunami M. Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute Heart Failure Registry (OPAR). Eur Heart J Cardiovasc Imaging. 2020;. [PMID: 32091079 DOI: 10.1093/ehjci/jeaa025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 van Brussel PM, Eeftinck Schattenkerk DW, Dobrowolski LC, de Winter RJ, Reekers JA, Verberne HJ, Vogt L, van den Born BJ. Effects of renal sympathetic denervation on cardiac sympathetic activity and function in patients with therapy resistant hypertension. Int J Cardiol. 2016;202:609-614. [PMID: 26447672 DOI: 10.1016/j.ijcard.2015.09.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
17 Frantellizzi V, Ricci M, Farcomeni A, Pontico M, Pani A, Vincentis G. Usefulness of 5 Minutes <sup>123</sup>I-mIBG Scan in Parkinson's Disease and Heart Failure. Curr Radiopharm 2020;13:120-9. [PMID: 31985388 DOI: 10.2174/1874471013666200127122033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kuramoto Y, Yamada T, Tamaki S, Okuyama Y, Morita T, Furukawa Y, Tanaka K, Iwasaki Y, Yasui T, Ueda H, Okada T, Kawasaki M, Levy WC, Komuro I, Fukunami M. Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure. Am J Cardiol 2011;107:1185-90. [PMID: 21349482 DOI: 10.1016/j.amjcard.2010.12.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
19 Borgquist R, Singh JP. An Electrophysiologist Perspective on Risk Stratification in Heart Failure: Can Better Understanding of the Condition of the Cardiac Sympathetic Nervous System Help? J Nucl Med 2015;56:59S-64S. [DOI: 10.2967/jnumed.114.148452] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
20 Dimitriu-Leen AC, Gimelli A, Al Younis I, Veltman CE, Verberne HJ, Wolterbeek R, Zandbergen-Harlaar S, Bax JJ, Scholte AJHA. The impact of acquisition time of planar cardiac (123)I-MIBG imaging on the late heart to mediastinum ratio. Eur J Nucl Med Mol Imaging 2016;43:326-32. [PMID: 26515715 DOI: 10.1007/s00259-015-3220-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
21 Grkovski M, Zanzonico PB, Modak S, Humm JL, Narula J, Pandit-Taskar N. F-18 meta-fluorobenzylguanidine PET imaging of myocardial sympathetic innervation. J Nucl Cardiol 2022. [PMID: 34993893 DOI: 10.1007/s12350-021-02813-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Asghar O, Arumugam P, Armstrong IS, Ray SG, Schmitt M, Malik RA. Individuals with impaired glucose tolerance demonstrate normal cardiac sympathetic innervation using I-123 mIBG scintigraphy. J Nucl Cardiol 2015;22:1262-8. [PMID: 25698476 DOI: 10.1007/s12350-015-0070-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
23 Climent E, Benaiges D, Pedro-Botet J. Hydrophilic or Lipophilic Statins? Front Cardiovasc Med 2021;8:687585. [PMID: 34095267 DOI: 10.3389/fcvm.2021.687585] [Reference Citation Analysis]
24 Cruz MC, Abreu A, Portugal G, Santa-clara H, Cunha PS, Oliveira MM, Santos V, Oliveira L, Rio P, Rodrigues I, Morais LA, Ferreira RC, Carmo MM. Relationship of left ventricular global longitudinal strain with cardiac autonomic denervation as assessed by 123I-mIBG scintigraphy in patients with heart failure with reduced ejection fraction submitted to cardiac resynchronization therapy: Assessment of cardiac autonomic denervation by GLS in patients with heart failure with reduced ejection fraction submitted to CRT. J Nucl Cardiol 2019;26:869-79. [DOI: 10.1007/s12350-017-1148-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Verberne HJ, Somsen GA, Povinec P, van Eck-Smit BL, Jacobson AF. Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ( (123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout. Eur J Nucl Med Mol Imaging 2009;36:1322-8. [PMID: 19259662 DOI: 10.1007/s00259-009-1093-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
26 Assante R, Acampa W. Dual isotope and multidetector camera: The best choices for a specific end-point. J Nucl Cardiol 2017;24:1370-3. [DOI: 10.1007/s12350-016-0520-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Chen W, Dilsizian V. Anatomy and Molecular Basis of Autonomic Innervation of the Heart. In: Dilsizian V, Narula J, editors. Atlas of Cardiac Innervation. Cham: Springer International Publishing; 2017. pp. 1-12. [DOI: 10.1007/978-3-319-45800-7_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
28 Travin MI. Current Clinical Applications and Next Steps for Cardiac Innervation Imaging. Curr Cardiol Rep. 2017;19:1. [PMID: 28084596 DOI: 10.1007/s11886-017-0817-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
29 Chen IY, Wu JC. Cardiovascular molecular imaging: focus on clinical translation. Circulation 2011;123:425-43. [PMID: 21282520 DOI: 10.1161/CIRCULATIONAHA.109.916338] [Cited by in Crossref: 108] [Cited by in F6Publishing: 66] [Article Influence: 9.8] [Reference Citation Analysis]
30 Rischpler C, Nekolla S, Schwaiger M. PET and SPECT in Heart Failure. Curr Cardiol Rep 2013;15. [DOI: 10.1007/s11886-012-0337-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
31 Travin MI, Matsunari I, Thomas GS, Nakajima K, Yoshinaga K. How Do We Establish Cardiac Sympathetic Nervous System Imaging with <sup>123</sup>I-<I>m</I>IBG in Clinical Practice? Perspectives and Lessons from Japan and the US. Annals of Nuclear Cardiology 2019;5:5-20. [DOI: 10.17996/anc.18-003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Marwick TH, Raman SV, Carrió I, Bax JJ. Recent Developments in Heart Failure Imaging. JACC: Cardiovascular Imaging 2010;3:429-39. [DOI: 10.1016/j.jcmg.2010.02.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
33 Goldberger JJ, Basu A, Boineau R, Buxton AE, Cain ME, Canty JM, Chen PS, Chugh SS, Costantini O, Exner DV. Risk stratification for sudden cardiac death: a plan for the future. Circulation. 2014;129:516-526. [PMID: 24470473 DOI: 10.1161/circulationaha.113.007149] [Cited by in Crossref: 100] [Cited by in F6Publishing: 52] [Article Influence: 12.5] [Reference Citation Analysis]
34 Kersting D, Settelmeier S, Mavroeidi IA, Herrmann K, Seifert R, Rischpler C. Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology. Int J Mol Sci 2022;23:3802. [PMID: 35409161 DOI: 10.3390/ijms23073802] [Reference Citation Analysis]
35 Yamada K, Shiraishi SY, Hamasaki T, Kuratsu J. Cardiac ¹²³I-MIBG scintigraphy as an outcome-predicting tool for subthalamic nucleus stimulation in Parkinson's disease. Acta Neurochir (Wien) 2010;152:2063-8. [PMID: 20927559 DOI: 10.1007/s00701-010-0825-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
36 Jacobson AF, Narula J. Introduction to cardiac neuronal imaging: a clinical perspective. J Nucl Med 2015;56 Suppl 4:3S-6S. [PMID: 26033903 DOI: 10.2967/jnumed.114.150458] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
37 Verschure DO, Poel E, De Vincentis G, Frantellizzi V, Nakajima K, Gheysens O, de Groot JR, Verberne HJ. The relation between cardiac 123I-mIBG scintigraphy and functional response 1 year after CRT implantation. Eur Heart J Cardiovasc Imaging 2021;22:49-57. [PMID: 32259839 DOI: 10.1093/ehjci/jeaa045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
38 van Ramshorst J, Beeres SL, Rodrigo SF, Dibbets-Schneider P, Scholte AJ, Fibbe WE, Zwaginga JJ, Schalij MJ, Bax JJ, Atsma DE. Effect of intramyocardial bone marrow-derived mononuclear cell injection on cardiac sympathetic innervation in patients with chronic myocardial ischemia. Int J Cardiovasc Imaging 2014;30:583-9. [PMID: 24481723 DOI: 10.1007/s10554-014-0377-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
39 Hachamovitch R, Nutter B, Menon V, Cerqueira MD. Predicting Risk Versus Predicting Potential Survival Benefit Using 123I-mIBG Imaging in Patients With Systolic Dysfunction Eligible for Implantable Cardiac Defibrillator Implantation: Analysis of Data From the Prospective ADMIRE-HF Study. Circ Cardiovasc Imaging 2015;8:e003110. [PMID: 26666380 DOI: 10.1161/CIRCIMAGING.114.003110] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
40 Gerson MC, Caldwell JH, Ananthasubramaniam K, Clements IP, Henzlova MJ, Amanullah A, Jacobson AF. Influence of diabetes mellitus on prognostic utility of imaging of myocardial sympathetic innervation in heart failure patients. Circ Cardiovasc Imaging 2011;4:87-93. [PMID: 21193691 DOI: 10.1161/CIRCIMAGING.110.954784] [Cited by in Crossref: 45] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
41 Fukuda K, Hasegawa S, Kawamura T, Waratani N, Hirata K, Higashimori A, Yokoi Y. Changes in cardiac sympathetic nerve activity on 123 I-metaiodobenzylguanidine scintigraphy after MitraClip therapy. ESC Heart Fail 2021;8:1590-5. [PMID: 33609015 DOI: 10.1002/ehf2.13266] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Silverio A, Polito MV, Pace L, D'Auria F, Vitulano G, Scarano M, Citro R, Galasso G, Piscione F. Predictors of outcome in patients with de novo diagnosis of heart failure with reduced ejection fraction: Role of combined myocardial and lung Iodine-123 Meta-Iodobenzylguanidine imaging. J Nucl Cardiol 2021;28:72-85. [PMID: 30761483 DOI: 10.1007/s12350-019-01637-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Juneau D, Erthal F, Chow BJW, Redpath C, Ruddy TD, Knuuti J, Beanlands RS. The role of nuclear cardiac imaging in risk stratification of sudden cardiac death. J Nucl Cardiol 2016;23:1380-98. [DOI: 10.1007/s12350-016-0599-8] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
44 Chen W, Cao Q, Dilsizian V. Variation of heart-to-mediastinal ratio in (123)I-mIBG cardiac sympathetic imaging: its affecting factors and potential corrections. Curr Cardiol Rep 2011;13:132-7. [PMID: 21221858 DOI: 10.1007/s11886-010-0157-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
45 Roberts G, Lloyd JJ, Kane JPM, Durcan R, Lawley S, Howe K, Petrides GS, O'Brien JT, Thomas AJ. Cardiac 123I-MIBG normal uptake values are population-specific: Results from a cohort of controls over 60 years of age. J Nucl Cardiol 2021;28:1692-701. [PMID: 31529384 DOI: 10.1007/s12350-019-01887-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
46 Patel HC, Rosen SD, Lindsay A, Hayward C, Lyon AR, di Mario C. Targeting the autonomic nervous system: Measuring autonomic function and novel devices for heart failure management. International Journal of Cardiology 2013;170:107-17. [DOI: 10.1016/j.ijcard.2013.10.058] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
47 Verberne HJ, van der Spank A, Bresser P, Somsen GA. The prognostic value of estimated glomerular filtration rate, amino-terminal portion of the pro-hormone B-type natriuretic peptide and parameters of cardiopulmonary exercise testing in patients with chronic heart failure. Heart Int 2012;7:e13. [PMID: 23185680 DOI: 10.4081/hi.2012.e13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
48 Verschure DO, Boot E, van Amelsvoort TA, Booij J, van Eck-Smit BL, Somsen GA, Verberne HJ. Cardiac sympathetic activity in 22q11.2 deletion syndrome. Int J Cardiol 2016;212:346-51. [PMID: 27057952 DOI: 10.1016/j.ijcard.2016.03.185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, Agostini D, Weiland F, Chandna H, Narula J; ADMIRE-HF Investigators. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55:2212-2221. [PMID: 20188504 DOI: 10.1016/j.jacc.2010.01.014] [Cited by in Crossref: 631] [Cited by in F6Publishing: 447] [Article Influence: 52.6] [Reference Citation Analysis]
50 . Myocardial innervation imaging: MIBG in clinical practice. Imaging 2021;13:87-97. [DOI: 10.1556/1647.2021.00021] [Reference Citation Analysis]
51 D'estanque E, Hedon C, Lattuca B, Bourdon A, Benkiran M, Verd A, Roubille F, Mariano-Goulart D. Optimization of a simultaneous dual-isotope 201Tl/123I-MIBG myocardial SPECT imaging protocol with a CZT camera for trigger zone assessment after myocardial infarction for routine clinical settings: Are delayed acquisition and scatter correction necessary? J Nucl Cardiol 2017;24:1361-9. [PMID: 27225516 DOI: 10.1007/s12350-016-0524-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
52 Treglia G, Cason E. Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis. J Neuroimaging 2012;22:111-7. [PMID: 21091814 DOI: 10.1111/j.1552-6569.2010.00532.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 47] [Article Influence: 5.7] [Reference Citation Analysis]
53 Tamaki N, Yoshinaga K. Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology. J Nucl Cardiol 2011;18:135-43. [PMID: 21082300 DOI: 10.1007/s12350-010-9305-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
54 van Bilsen M, Patel HC, Bauersachs J, Böhm M, Borggrefe M, Brutsaert D, Coats AJS, de Boer RA, de Keulenaer GW, Filippatos GS, Floras J, Grassi G, Jankowska EA, Kornet L, Lunde IG, Maack C, Mahfoud F, Pollesello P, Ponikowski P, Ruschitzka F, Sabbah HN, Schultz HD, Seferovic P, Slart RHJA, Taggart P, Tocchetti CG, Van Laake LW, Zannad F, Heymans S, Lyon AR. The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2017;19:1361-78. [PMID: 28949064 DOI: 10.1002/ejhf.921] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 12.0] [Reference Citation Analysis]
55 Alvi R, Miller EJ, Zonouz TH, Sandoval V, Tariq N, Lampert R, Sinusas AJ, Liu Y. Quantification and Determination of Normal 123 I-Meta Iodobenzylguanidine Heart-to-Mediastinum Ratio (HMR) from Cardiac SPECT/CT and Correlation with Planar HMR. J Nucl Med 2018;59:652-8. [DOI: 10.2967/jnumed.117.197152] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
56 Jain KK, Hauptman PJ, Spertus JA, Kennedy KF, Bateman TM, Jacobson AF, Stolker JM. Incremental utility of iodine-123 meta-iodobenzylguanidine imaging beyond established heart failure risk models. J Card Fail 2014;20:577-83. [PMID: 24951931 DOI: 10.1016/j.cardfail.2014.06.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
57 Mahida S, Sacher F, Dubois R, Sermesant M, Bogun F, Haïssaguerre M, Jaïs P, Cochet H. Cardiac Imaging in Patients With Ventricular Tachycardia. Circulation 2017;136:2491-507. [DOI: 10.1161/circulationaha.117.029349] [Cited by in Crossref: 34] [Cited by in F6Publishing: 11] [Article Influence: 6.8] [Reference Citation Analysis]
58 Petretta M, Pellegrino T, Cuocolo A. Cardiac neuronal imaging with 123I-meta-iodobenzylguanidine in heart failure: implications of endpoint selection and quantitative analysis on clinical decisions. Eur J Nucl Med Mol Imaging 2014;41:1663-5. [DOI: 10.1007/s00259-014-2827-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
59 Travin MI, Matsunari I, Thomas GS, Nakajima K, Yoshinaga K. How do we establish cardiac sympathetic nervous system imaging with 123I-mIBG in clinical practice? J Nucl Cardiol. 2019;26:1434-1451. [PMID: 30178272 DOI: 10.1007/s12350-018-1394-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
60 Siebermair J, Lehner S, Sattler SM, Rizas KD, Beckmann BM, Becker A, Schiller J, Metz C, Zacherl M, Vonderlin N, Rassaf T, Dobrev D, Rischpler C, Kääb S, Hacker M, Todica A, Wakili R. Left-ventricular innervation assessed by 123I-SPECT/CT is associated with cardiac events in inherited arrhythmia syndromes. Int J Cardiol 2020;312:129-35. [PMID: 32201099 DOI: 10.1016/j.ijcard.2020.03.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Kelesidis I, Travin MI. Use of cardiac radionuclide imaging to identify patients at risk for arrhythmic sudden cardiac death. J Nucl Cardiol 2012;19:142-52. [DOI: 10.1007/s12350-011-9482-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
62 Clements IP, Garcia EV, Chen J, Folks RD, Butler J, Jacobson AF. Quantitative iodine-123-metaiodobenzylguanidine (MIBG) SPECT imaging in heart failure with left ventricular systolic dysfunction: Development and validation of automated procedures in conjunction with technetium-99m tetrofosmin myocardial perfusion SPECT. J Nucl Cardiol 2016;23:425-35. [PMID: 25788403 DOI: 10.1007/s12350-015-0097-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
63 Tan MP, Murray A, Hawkins T, Chadwick TJ, Kerr SR, Parry SW. Cardiac Iodine-123-Meta-Iodo-Benzylguanidine Uptake in Carotid Sinus Hypersensitivity. PLoS One 2015;10:e0126241. [PMID: 26057525 DOI: 10.1371/journal.pone.0126241] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
64 Arimoto T, Tada H, Igarashi M, Sekiguchi Y, Sato A, Koyama T, Yamasaki H, Machino T, Kuroki K, Kuga K, Aonuma K. High Washout Rate of Iodine-123-Metaiodobenzylguanidine Imaging Predicts the Outcome of Catheter Ablation of Atrial Fibrillation. Journal of Cardiovascular Electrophysiology 2011;22:1297-304. [DOI: 10.1111/j.1540-8167.2011.02123.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
65 Borovac JA, D'Amario D, Bozic J, Glavas D. Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers. World J Cardiol 2020; 12(8): 373-408 [PMID: 32879702 DOI: 10.4330/wjc.v12.i8.373] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
66 Skovgaard D, Holmvang L, Bang LE, Lønborg J, Hasbak P. Imaging of takotsubo cardiomyopathy. Clin Nucl Med 2010;35:967-71. [PMID: 21206235 DOI: 10.1097/RLU.0b013e3181f9dfcd] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
67 Wan N, Travin MI. Cardiac Imaging With 123I-meta-iodobenzylguanidine and Analogous PET Tracers: Current Status and Future Perspectives. Semin Nucl Med 2020;50:331-48. [PMID: 32540030 DOI: 10.1053/j.semnuclmed.2020.03.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
68 Adak S, Bhalla R, Vijaya Raj KK, Mandal S, Pickett R, Luthra SK. Radiotracers for SPECT imaging: current scenario and future prospects. ract 2012;100:95-107. [DOI: 10.1524/ract.2011.1891] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
69 Verschure DO, Somsen GA, van Eck-Smit BL, Verberne HJ. Renal Function in Relation to Cardiac (123)I-MIBG Scintigraphy in Patients with Chronic Heart Failure. Int J Mol Imaging 2012;2012:434790. [PMID: 22666580 DOI: 10.1155/2012/434790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
70 Carrió I, Cowie MR, Yamazaki J, Udelson J, Camici PG. Cardiac Sympathetic Imaging With mIBG in Heart Failure. JACC: Cardiovascular Imaging 2010;3:92-100. [DOI: 10.1016/j.jcmg.2009.07.014] [Cited by in Crossref: 118] [Cited by in F6Publishing: 95] [Article Influence: 9.8] [Reference Citation Analysis]
71 Martins da Silva MI, Vidigal Ferreira MJ, Morão Moreira AP. Iodine-123-metaiodobenzylguanidine scintigraphy in risk stratification of sudden death in heart failure. Rev Port Cardiol 2013;32:509-16. [PMID: 23731734 DOI: 10.1016/j.repc.2012.11.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
72 Rischpler C, Fukushima K, Isoda T, Javadi MS, Dannals RF, Abraham R, Wahl R, Bengel FM, Higuchi T. Discrepant uptake of the radiolabeled norepinephrine analogues hydroxyephedrine (HED) and metaiodobenzylguanidine (MIBG) in rat hearts. Eur J Nucl Med Mol Imaging 2013;40:1077-83. [DOI: 10.1007/s00259-013-2393-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
73 Valborgland T, Isaksen K, Munk PS, Grabowski ZP, Larsen AI. Impact of an exercise training program on cardiac neuronal function in heart failure patients on optimal medical therapy : A randomized Iodine-123 metaiodobenzylguanidine scintigraphy study. J Nucl Cardiol 2018;25:1164-71. [PMID: 28097476 DOI: 10.1007/s12350-016-0724-8] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
74 Muxí A, Paredes P, Navales I, Valldeoriola F, Gaig C, Lomeña F, de la Cerda A, Solà O, Domenech B, Tolosa E, Pons F. Diagnostic cutoff points for ¹²³I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson's disease. Eur J Nucl Med Mol Imaging 2011;38:1139-46. [PMID: 21373765 DOI: 10.1007/s00259-011-1754-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
75 Agostini D, Ananthasubramaniam K, Chandna H, Friberg L, Hudnut A, Koren M, Miyamoto MI, Senior R, Shah M, Travin MI, Dahl JV, Chen K, Levy WC; on behalf of the ADMIRE-HF investigators. Prognostic usefulness of planar 123I-MIBG scintigraphic images of myocardial sympathetic innervation in congestive heart failure: Follow-Up data from ADMIRE-HF. J Nucl Cardiol 2021;28:1490-503. [DOI: 10.1007/s12350-019-01859-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
76 Laursen AH, Thune JJ, Hutchings M, Hasbak P, Kjaer A, Elming MB, Ripa RS. 123 I-MIBG imaging for detection of anthracycline-induced cardiomyopathy. Clin Physiol Funct Imaging 2018;38:176-85. [DOI: 10.1111/cpf.12419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
77 García-González P, Fabregat-Andrés Ó, Cozar-Santiago P, Sánchez-Jurado R, Estornell-Erill J, Valle-Muñoz A, Quesada-Dorador A, Payá-Serrano R, Ferrer-Rebolleda J, Ridocci-Soriano F. Cardiac sympathetic innervation assessed with (123)I-MIBG retains prognostic utility in diabetic patients with severe left ventricular dysfunction evaluated for primary prevention implantable cardioverter-defibrillator. Rev Esp Med Nucl Imagen Mol 2016;35:74-80. [PMID: 26514320 DOI: 10.1016/j.remn.2015.08.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
78 Verschure DO, de Wit TC, Bongers V, Hagen PJ, Sonneck-Koenne C, D'Aron J, Huber K, van Eck-Smit BL, Knoll P, Somsen GA, Mirzaei S, Verberne HJ. ¹²³I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activity. Nucl Med Commun 2015;36:279-85. [PMID: 25415845 DOI: 10.1097/MNM.0000000000000238] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
79 Verschure DO, Bongers V, Hagen PJ, Somsen GA, van Eck-Smit BL, Verberne HJ. Impact of a predefined mediastinal ROI on inter-observer variability of planar ¹²³I-MIBG heart-to-mediastinum ratio. J Nucl Cardiol 2014;21:605-13. [PMID: 24493412 DOI: 10.1007/s12350-014-9854-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
80 Liga R, Scholte AJHA. Neuro-cardiac imaging has a proven value in patient management: Con. J Nucl Cardiol 2017;24:1583-7. [PMID: 28593535 DOI: 10.1007/s12350-017-0947-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
81 Fernandes Silva MM, Bacal F, Roque JM, Teixeira-neto IS, Carvas Junior N, Bocchi EA, Guimarães GV. Age-Related Maximum Heart Rate Among Ischemic and Nonischemic Heart Failure Patients Receiving β-Blockade Therapy. Journal of Cardiac Failure 2012;18:831-6. [DOI: 10.1016/j.cardfail.2012.10.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
82 Beller GA. Recent advances and future trends in multimodality cardiac imaging. Heart Lung Circ 2010;19:193-209. [PMID: 20138581 DOI: 10.1016/j.hlc.2009.11.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
83 Fujita W, Matsunari I, Aoki H, Nekolla SG, Kajinami K. Prediction of all-cause death using (11)C-hydroxyephedrine positron emission tomography in Japanese patients with left ventricular dysfunction. Ann Nucl Med 2016;30:461-7. [PMID: 27194040 DOI: 10.1007/s12149-016-1081-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
84 Doi T, Nakata T, Hashimoto A, Yuda S, Wakabayashi T, Kouzu H, Kaneko N, Hase M, Tsuchihashi K, Miura T. Cardiac Mortality Assessment Improved by Evaluation of Cardiac Sympathetic Nerve Activity in Combination with Hemoglobin and Kidney Function in Chronic Heart Failure Patients. J Nucl Med 2012;53:731-40. [DOI: 10.2967/jnumed.111.095786] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
85 Treglia G, Stefanelli A, Cason E, Cocciolillo F, Di Giuda D, Giordano A. Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: A systematic review and a meta-analysis. Clinical Neurology and Neurosurgery 2011;113:823-9. [DOI: 10.1016/j.clineuro.2011.09.004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
86 Wu J, Liu H, Hashemi Zonouz T, Sandoval VM, Mohy-ud-din H, Lampert RJ, Sinusas AJ, Liu C, Liu Y. A blind deconvolution method incorporated with anatomical-based filtering for partial volume correction: Validations with 123 I-mIBG cardiac SPECT/CT. Med Phys 2017;44:6435-46. [DOI: 10.1002/mp.12622] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
87 Tamura A, Ando S, Goto Y, Kawano Y, Shinozaki K, Kotoku M, Kadota J. Washout Rate of Cardiac Iodine-123 Metaiodobenzylguanidine is High in Chronic Heart Failure Patients With Central Sleep Apnea. Journal of Cardiac Failure 2010;16:728-33. [DOI: 10.1016/j.cardfail.2010.04.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
88 Mastrocola LE, Amorim BJ, Vitola JV, Brandão SCS, Grossman GB, Lima RSL, Lopes RW, Chalela WA, Carreira LCTF, Araújo JRN, Mesquita CT, Meneghetti JC. Update of the Brazilian Guideline on Nuclear Cardiology - 2020. Arq Bras Cardiol 2020;114:325-429. [PMID: 32215507 DOI: 10.36660/abc.20200087] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 J Boogers M, E Veltman C, J Bax J. Cardiac autonomic nervous system in heart failure: imaging technique and clinical implications. Curr Cardiol Rev 2011;7:35-42. [PMID: 22294973 DOI: 10.2174/157340311795677725] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
90 Flotats A, Carrió I, Agostini D, Le Guludec D, Marcassa C, Schäfers M, Somsen GA, Unlu M, Verberne HJ. Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging. 2010;37:1802-1812. [PMID: 20577740 DOI: 10.1007/s00259-010-1491-4] [Cited by in Crossref: 235] [Cited by in F6Publishing: 164] [Article Influence: 19.6] [Reference Citation Analysis]
91 Oliveira SM, Martins E, Oliveira A, Pinho T, Gavina C, Faria T, Silva-cardoso JC, Pereira J, Maciel MJ. Cardiac 123I-MIBG scintigraphy and arrhythmic risk in left ventricular noncompaction. Revista Portuguesa de Cardiologia 2012;31:247-50. [DOI: 10.1016/j.repc.2012.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
92 Verschure DO, Lutter R, van Eck-Smit BLF, Somsen GA, Verberne HJ. Myocardial 123I-mIBG scintigraphy in relation to markers of inflammation and long-term clinical outcome in patients with stable chronic heart failure. J Nucl Cardiol 2018;25:845-53. [PMID: 27858345 DOI: 10.1007/s12350-016-0697-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
93 Takamura M, Murai H, Okabe Y, Okuyama Y, Hamaoka T, Mukai Y, Tokuhisa H, Inoue O, Takashima SI, Kato T, Matsuo S, Usui S, Furusho H, Kaneko S. Significant correlation between renal 123I-metaiodobenzylguanidine scintigraphy and muscle sympathetic nerve activity in patients with primary hypertension. J Nucl Cardiol 2017;24:363-71. [PMID: 28070734 DOI: 10.1007/s12350-016-0760-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
94 Aikawa T, Naya M, Obara M, Oyama-Manabe N, Manabe O, Magota K, Ito YM, Katoh C, Tamaki N. Regional interaction between myocardial sympathetic denervation, contractile dysfunction, and fibrosis in heart failure with preserved ejection fraction: 11C-hydroxyephedrine PET study. Eur J Nucl Med Mol Imaging. 2017;44:1897-1905. [PMID: 28653180 DOI: 10.1007/s00259-017-3760-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
95 Chimura M, Yamada S, Taniguchi Y, Yasaka Y, Kawai H. Late gadolinium enhancement on cardiac magnetic resonance combined with 123I- metaiodobenzylguanidine scintigraphy strongly predicts long-term clinical outcome in patients with dilated cardiomyopathy. PLoS One 2019;14:e0217865. [PMID: 31220100 DOI: 10.1371/journal.pone.0217865] [Reference Citation Analysis]
96 Travin MI, Feng D, Taub CC. Novel Imaging Approaches for Predicting Arrhythmic Risk. Circ Cardiovasc Imaging 2015;8:e003019. [PMID: 26565012 DOI: 10.1161/CIRCIMAGING.115.003019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
97 Travin MI. Cardiac autonomic imaging with SPECT tracers. J Nucl Cardiol 2013;20:128-43. [DOI: 10.1007/s12350-012-9655-1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
98 Travin MI. Assessing arrhythmic risk with 123I-mIBG and analogous tracers: Image interpretation from a different viewpoint. J Nucl Cardiol 2019;26:118-22. [DOI: 10.1007/s12350-017-0968-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
99 Nakajima K, Okuda K, Yoshimura M, Matsuo S, Wakabayashi H, Imanishi Y, Kinuya S. Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations. J Nucl Cardiol 2014;21:970-8. [PMID: 24942608 DOI: 10.1007/s12350-014-9916-2] [Cited by in Crossref: 91] [Cited by in F6Publishing: 58] [Article Influence: 11.4] [Reference Citation Analysis]
100 Narumi H, Takano H, Shindo S, Fujita M, Mizuma H, Kuwabara Y, Komuro I; on behalf of the VART Investigators. Effects of valsartan and amlodipine on cardiorenal protection in Japanese hypertensive patients: the Valsartan Amlodipine Randomized Trial. Hypertens Res 2011;34:62-9. [DOI: 10.1038/hr.2010.186] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
101 Peix A, Mesquita CT, Paez D, Pereira CC, Felix R, Gutierrez C, Jaimovich R, Ianni BM, Soares J Jr, Olaya P, Rodriguez MV, Flotats A, Giubbini R, Travin M, Garcia EV. Nuclear medicine in the management of patients with heart failure: guidance from an expert panel of the International Atomic Energy Agency (IAEA). Nucl Med Commun 2014;35:818-23. [PMID: 24781009 DOI: 10.1097/MNM.0000000000000143] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 2.1] [Reference Citation Analysis]
102 Verberne HJ. Assessment of cardiac sympathetic innervation with (123)I-mIBG SPECT comes to life: need for standardization! Eur Heart J Cardiovasc Imaging 2016;17:391-2. [PMID: 26819325 DOI: 10.1093/ehjci/jev348] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
103 Travin MI. Can the promise of radionuclide cardiac innervation imaging be fulfilled? J Nucl Cardiol . [DOI: 10.1007/s12350-021-02866-6] [Reference Citation Analysis]
104 Klein T, Dilsizian V, Cao Q, Chen W, Dickfeld TM. The potential role of iodine-123 metaiodobenzylguanidine imaging for identifying sustained ventricular tachycardia in patients with cardiomyopathy. Curr Cardiol Rep 2013;15:359. [PMID: 23536110 DOI: 10.1007/s11886-013-0359-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
105 de Peuter OR, Verberne HJ, Kok WE, van den Bogaard B, Schaap MC, Nieuwland R, Meijers JC, Somsen GA, Bakx A, Kamphuisen PW. Differential effects of nonselective versus selective β-blockers on cardiac sympathetic activity and hemostasis in patients with heart failure. J Nucl Med 2013;54:1733-9. [PMID: 23970363 DOI: 10.2967/jnumed.113.120477] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
106 Zelt JG, deKemp RA, Rotstein BH, Nair GM, Narula J, Ahmadi A, Beanlands RS, Mielniczuk LM. Nuclear Imaging of the Cardiac Sympathetic Nervous System. JACC: Cardiovascular Imaging 2020;13:1036-54. [DOI: 10.1016/j.jcmg.2019.01.042] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
107 Agostini D, Carrio I, Verberne HJ. How to use myocardial 123I-MIBG scintigraphy in chronic heart failure. Eur J Nucl Med Mol Imaging. 2009;36:555-559. [PMID: 18989666 DOI: 10.1007/s00259-008-0976-x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 46] [Article Influence: 4.8] [Reference Citation Analysis]
108 Verberne HJ, Somsen GA, van Eck-Smit BL. 123I-meta-iodobenzylguanidine in patients with chronic heart failure: technical aspects, conceptual issues, and future prospects. Nucl Med Commun 2009;30:411-4. [PMID: 19417575 DOI: 10.1097/MNM.0b013e3283293374] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
109 Moreira RI, Abreu A, Portugal G, Oliveira L, Oliveira M, Rodrigues I, Cruz MC, Cunha PS, Santos V, Clara HS, Carmo MM, Ferreira RC. Prognostic effect and modulation of cardiac sympathetic function in heart failure patients treated with cardiac resynchronization therapy. J Nucl Cardiol 2020;27:283-90. [DOI: 10.1007/s12350-018-1357-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
110 Travin MI. Clinical Applications of Myocardial Innervation Imaging. Cardiol Clin 2016;34:133-47. [PMID: 26590785 DOI: 10.1016/j.ccl.2015.06.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
111 Mitropoulou P, Georgiopoulos G, Figliozzi S, Klettas D, Nicoli F, Masci PG. Multi-Modality Imaging in Dilated Cardiomyopathy: With a Focus on the Role of Cardiac Magnetic Resonance. Front Cardiovasc Med 2020;7:97. [PMID: 32714942 DOI: 10.3389/fcvm.2020.00097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
112 Verberne HJ, Verschure DO, Somsen GA, van Eck-Smit BL, Jacobson AF. Vascular time-activity variation in patients undergoing ¹²³I-MIBG myocardial scintigraphy: implications for quantification of cardiac and mediastinal uptake. Eur J Nucl Med Mol Imaging 2011;38:1132-8. [PMID: 21461736 DOI: 10.1007/s00259-011-1783-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
113 Despas F, Guerriero E, Galinier M, Senard J, Pathak A. Limited prognostic value of cardiac metaiodobenzylguanidine in advanced heart failure. J Heart Lung Transplant 2010;29:591-2. [PMID: 20044275 DOI: 10.1016/j.healun.2009.10.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
114 Travin MI. Cardiac Radionuclide Imaging to Assess Patients With Heart Failure. Seminars in Nuclear Medicine 2014;44:294-313. [DOI: 10.1053/j.semnuclmed.2014.04.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
115 Travin MI, Henzlova MJ, van Eck-Smit BLF, Jain D, Carrió I, Folks RD, Garcia EV, Jacobson AF, Verberne HJ. Assessment of 123I-mIBG and 99mTc-tetrofosmin single-photon emission computed tomographic images for the prediction of arrhythmic events in patients with ischemic heart failure: Intermediate severity innervation defects are associated with higher arrhythmic risk. J Nucl Cardiol 2017;24:377-91. [PMID: 26791866 DOI: 10.1007/s12350-015-0336-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
116 Tamaki N, Kuge Y, Yoshinaga K. Molecular imaging in heart failure patients. Clin Transl Imaging 2013;1:341-51. [PMID: 24765617 DOI: 10.1007/s40336-013-0034-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
117 Wu J, Lin SF, Gallezot JD, Chan C, Prasad R, Thorn SL, Stacy MR, Huang Y, Zonouz TH, Liu YH, Lampert RJ, Carson RE, Sinusas AJ, Liu C. Quantitative Analysis of Dynamic 123I-mIBG SPECT Imaging Data in Healthy Humans with a Population-Based Metabolite Correction Method. J Nucl Med 2016;57:1226-32. [PMID: 27081169 DOI: 10.2967/jnumed.115.171710] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
118 Sakamoto F, Shiraishi S, Tsuda N, Ogasawara K, Yoshida M, Yuki H, Hashimoto M, Tomiguchi S, Ikeda M, Yamashita Y. 123I-MIBG myocardial scintigraphy for the evaluation of Lewy body disease: are delayed images essential? Is visual assessment useful? Br J Radiol 2016;89:20160144. [PMID: 27222274 DOI: 10.1259/bjr.20160144] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
119 Clements IP, Kelkar AA, Garcia EV, Butler J, Chen J, Folks R, Jacobson AF. Prognostic significance of 123 I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure. Eur Heart J Cardiovasc Imaging 2016;17:384-90. [DOI: 10.1093/ehjci/jev295] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 3.1] [Reference Citation Analysis]
120 Veltman CE, Boogers MJ, Meinardi JE, Al Younis I, Dibbets-Schneider P, Van der Wall EE, Bax JJ, Scholte AJ. Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure. Eur J Nucl Med Mol Imaging. 2012;39:1599-1608. [PMID: 22790878 DOI: 10.1007/s00259-012-2180-2] [Cited by in Crossref: 55] [Cited by in F6Publishing: 38] [Article Influence: 5.5] [Reference Citation Analysis]
121 Hage FG, Iskandrian AE. Cardiac autonomic denervation in diabetes mellitus. Circ Cardiovasc Imaging 2011;4:79-81. [PMID: 21406659 DOI: 10.1161/CIRCIMAGING.111.963967] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
122 Laursen AH, Ripa RS, Hasbak P, Kjær A, Elming MB, Køber L, Hutchings M, Thune JJ. 123I-MIBG for detection of subacute doxorubicin-induced cardiotoxicity in patients with malignant lymphoma. J Nucl Cardiol 2020;27:931-9. [PMID: 30569409 DOI: 10.1007/s12350-018-01566-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
123 Fernandes IA, Vianna LC, Freitas RA, Miranda SM, Mesquita ET, Mesquita CT, da Nóbrega ACL. Statin therapy and cardiac sympathetic activity in patients with heart failure: A 123Iodine-metaiodobenzylguanidine myocardial scintigraphy study. International Journal of Cardiology 2014;176:1181-3. [DOI: 10.1016/j.ijcard.2014.07.243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
124 Abdulghani M, Duell J, Smith M, Chen W, Bentzen SM, Asoglu R, Klein T, Bob-manuel T, Saliaris A, See V, Shorofsky S, Dilsizian V, Dickfeld T. Global and Regional Myocardial Innervation Before and After Ablation of Drug-Refractory Ventricular Tachycardia Assessed with 123 I-MIBG. J Nucl Med 2015;56:52S-8S. [DOI: 10.2967/jnumed.115.155143] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
125 Narula J, Gerson M, Thomas GS, Cerqueira MD, Jacobson AF. ¹²³I-MIBG Imaging for Prediction of Mortality and Potentially Fatal Events in Heart Failure: The ADMIRE-HFX Study. J Nucl Med 2015;56:1011-8. [PMID: 26069309 DOI: 10.2967/jnumed.115.156406] [Cited by in Crossref: 51] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
126 Koutelou M, Katsikis A, Flevari P, Theodorakis G, Livanis E, Georgiadis M, Voudris V, Kremastinos D. Predictive value of cardiac autonomic indexes and MIBG washout in ICD recipients with mild to moderate heart failure. Ann Nucl Med 2009;23:677-84. [DOI: 10.1007/s12149-009-0289-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
127 Eckelman WC, Dilsizian V. Chemistry and biology of radiotracers that target changes in sympathetic and parasympathetic nervous systems in heart disease. J Nucl Med 2015;56 Suppl 4:7S-10S. [PMID: 26033907 DOI: 10.2967/jnumed.114.142802] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
128 Nekolla SG, Martinez-Moeller A, Saraste A. PET and MRI in cardiac imaging: from validation studies to integrated applications. Eur J Nucl Med Mol Imaging. 2009;36 Suppl 1:S121-S130. [PMID: 19104798 DOI: 10.1007/s00259-008-0980-1] [Cited by in Crossref: 90] [Cited by in F6Publishing: 68] [Article Influence: 6.9] [Reference Citation Analysis]
129 Miranda SM, Moscavitch SD, Carestiato LR, Felix RM, Rodrigues RC, Messias LR, Azevedo JC, Nóbrega AC, Mesquita ET, Mesquita CT. Cardiac I123-MIBG correlates better than ejection fraction with symptoms severity in systolic heart failure. Arq Bras Cardiol 2013;101:4-8. [PMID: 23917506 DOI: 10.5935/abc.20130111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
130 Giovanni S, Stefano M, Teresa SM, Margherita C, Giovanni B, Umberto P, Paola P, Giacomo C, Pierfranco D, Alfonso G, Riccardo C, Claudio M. Incremental prognostic value of myocardial neuroadrenergic damage in patients with chronic congestive heart failure: An iodine-123 meta-iodobenzylguanidine scintigraphy study. J Nucl Cardiol 2020;27:1787-97. [PMID: 30377997 DOI: 10.1007/s12350-018-01467-0] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
131 Sacre JW, Franjic B, Coombes JS, Marwick TH, Baumert M. QT interval variability in type 2 diabetic patients with cardiac sympathetic dysinnervation assessed by 123I-metaiodobenzylguanidine scintigraphy. J Cardiovasc Electrophysiol 2013;24:305-13. [PMID: 23210722 DOI: 10.1111/jce.12039] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
132 Rengo G, Pagano G, Vitale DF, Formisano R, Komici K, Petraglia L, Parisi V, Femminella GD, de Lucia C, Paolillo S, Cannavo A, Attena E, Pellegrino T, Dellegrottaglie S, Memmi A, Trimarco B, Cuocolo A, Filardi PP, Leosco D, Ferrara N. Impact of aging on cardiac sympathetic innervation measured by 123I-mIBG imaging in patients with systolic heart failure. Eur J Nucl Med Mol Imaging. 2016;43:2392-2400. [PMID: 27287990 DOI: 10.1007/s00259-016-3432-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
133 Giubbini R, Milan E, Bertagna F, Mut F, Metra M, Rodella C, Dondi M. Nuclear cardiology and heart failure. Eur J Nucl Med Mol Imaging 2009;36:2068-80. [PMID: 19672592 DOI: 10.1007/s00259-009-1246-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
134 Roberts G, Lloyd JJ, Petrides GS, O'Brien JT, Thomas AJ. Cardiac 123I-MIBG planar heart to mediastinum ratios depend on patient size; phantom studies suggest SPECT-CT could improve quantification. Biomed Phys Eng Express 2019;6:015011. [PMID: 33438599 DOI: 10.1088/2057-1976/ab5c09] [Reference Citation Analysis]
135 Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol. 2009;54:1747-1762. [PMID: 19874988 DOI: 10.1016/j.jacc.2009.05.015] [Cited by in Crossref: 550] [Cited by in F6Publishing: 479] [Article Influence: 42.3] [Reference Citation Analysis]
136 Nakajima K, Nakata T, Yamada T, Yamashina S, Momose M, Kasama S, Matsui T, Matsuo S, Travin MI, Jacobson AF. A prediction model for 5-year cardiac mortality in patients with chronic heart failure using ¹²³I-metaiodobenzylguanidine imaging. Eur J Nucl Med Mol Imaging 2014;41:1673-82. [PMID: 24663289 DOI: 10.1007/s00259-014-2759-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
137 Travin MI. It's not all in the numbers. J Nucl Cardiol 2016;23:436-41. [PMID: 25802176 DOI: 10.1007/s12350-015-0105-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
138 Jacobson AF, Matsuoka DT. Influence of myocardial region of interest definition on quantitative analysis of planar 123I-mIBG images. Eur J Nucl Med Mol Imaging 2013;40:558-64. [PMID: 23359065 DOI: 10.1007/s00259-012-2336-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
139 Parker MW, Sood N, Ahlberg AW, Jacobson AF, Heller GV, Lundbye JB. Relationship between quantitative cardiac neuronal imaging with 123I-meta-iodobenzylguanidine and hospitalization in patients with heart failure. Eur J Nucl Med Mol Imaging 2014;41:1666-72. [DOI: 10.1007/s00259-014-2819-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
140 Werner RA, Chen X, Hirano M, Rowe SP, Lapa C, Javadi MS, Higuchi T. SPECT vs. PET in cardiac innervation imaging: clash of the titans. Clin Transl Imaging 2018;6:293-303. [PMID: 30148120 DOI: 10.1007/s40336-018-0289-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
141 Verschure DO, Baas F, van Eck-Smit BLF, Somsen GA, Verberne HJ. Polymorphism of SLC6A2 gene does not influence outcome of myocardial 123I-mIBG scintigraphy in patients with chronic heart failure. J Nucl Cardiol 2018;25:900-6. [PMID: 27844334 DOI: 10.1007/s12350-016-0722-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
142 Katsikis A, Ekonomopoulos G, Papaioannou S, Kouzoumi A, Koutelou M. Reversible reduction of cardiac sympathetic innervation after coronary artery bypass graft surgery: an observational study using serial iodine 123-labeled meta-iodobenzyl-guanidine (MIBG) imaging. J Thorac Cardiovasc Surg 2012;144:210-6. [PMID: 22487439 DOI: 10.1016/j.jtcvs.2012.03.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
143 Lindberg L, Brinth LS, Bergmann ML, Kristensen B, Hansen TW, Hasbak P, Thomsen JF, Eldrup E, Jensen LT. Autonomic nervous system activity in primary Raynaud's phenomenon: Heart rate variability, plasma catecholamines and [123 I]MIBG heart scintigraphy. Clin Physiol Funct Imaging 2021. [PMID: 34972251 DOI: 10.1111/cpf.12737] [Reference Citation Analysis]
144 Asghar O, Arumugam P, Armstrong I, Ray S, Schmitt M, Malik RA. Iodine-123 metaiodobenzylguanidine scintigraphy for the assessment of cardiac sympathetic innervation and the relationship with cardiac autonomic function in healthy adults using standardized methods. Nucl Med Commun 2017;38:44-50. [PMID: 27898646 DOI: 10.1097/MNM.0000000000000608] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
145 Shah AM, Bourgoun M, Narula J, Jacobson AF, Solomon SD. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure. JACC Cardiovasc Imaging. 2012;5:1139-1146. [PMID: 23153914 DOI: 10.1016/j.jcmg.2012.02.019] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
146 Scholtens AM, Verberne HJ. Innervation imaging in arrhythmia and arrhythmogenic disease. Clin Transl Imaging 2015;3:373-8. [DOI: 10.1007/s40336-015-0136-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
147 Drakos SG, Athanasoulis T, Malliaras KG, Terrovitis JV, Diakos N, Koudoumas D, Ntalianis AS, Theodoropoulos SP, Yacoub MH, Nanas JN. Myocardial Sympathetic Innervation and Long-Term Left Ventricular Mechanical Unloading. JACC: Cardiovascular Imaging 2010;3:64-70. [DOI: 10.1016/j.jcmg.2009.10.008] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
148 Schwartz RG, Jain D, Storozynsky E. Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively. J Nucl Cardiol 2013;20:443-64. [DOI: 10.1007/s12350-013-9707-1] [Cited by in Crossref: 69] [Cited by in F6Publishing: 51] [Article Influence: 7.7] [Reference Citation Analysis]
149 Travin MI. Neurocardiac imaging has a proven value in patient management. J Nucl Cardiol 2017;24:1588-93. [PMID: 28593534 DOI: 10.1007/s12350-017-0948-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
150 Jacobson AF, White S, Travin MI, Tseng C. Impact of concomitant medication use on myocardial 123I-mIBG imaging results in patients with heart failure. Nuclear Medicine Communications 2017;38:141-8. [DOI: 10.1097/mnm.0000000000000619] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
151 Boogers MJ, Fukushima K, Bengel FM, Bax JJ. The role of nuclear imaging in the failing heart: myocardial blood flow, sympathetic innervation, and future applications. Heart Fail Rev 2011;16:411-23. [PMID: 20938735 DOI: 10.1007/s10741-010-9196-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
152 Dimitriu-Leen AC, Scholte AJ, Jacobson AF. 123I-MIBG SPECT for Evaluation of Patients with Heart Failure. J Nucl Med 2015;56 Suppl 4:25S-30S. [PMID: 26033900 DOI: 10.2967/jnumed.115.157503] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
153 Gupta S, Amanullah A. Radionuclide imaging of cardiac sympathetic innervation in heart failure: unlocking untapped potential. Heart Fail Rev 2015;20:215-26. [PMID: 25135163 DOI: 10.1007/s10741-014-9456-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
154 Henzlova MJ, Duvall WL, Einstein AJ, Travin MI, Verberne HJ. ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers. J Nucl Cardiol 2016;23:606-39. [PMID: 26914678 DOI: 10.1007/s12350-015-0387-x] [Cited by in Crossref: 274] [Cited by in F6Publishing: 158] [Article Influence: 68.5] [Reference Citation Analysis]
155 Fallavollita JA, Canty JM. Dysinnervated but viable myocardium in ischemic heart disease. J Nucl Cardiol. 2010;17:1107-1115. [PMID: 20857351 DOI: 10.1007/s12350-010-9292-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
156 Flotats A, Carrió I. Radionuclide noninvasive evaluation of heart failure beyond left ventricular function assessment. J Nucl Cardiol 2009;16:304-15. [DOI: 10.1007/s12350-009-9064-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
157 Treglia G, Cason E, Stefanelli A, Cocciolillo F, Di Giuda D, Fagioli G, Giordano A. MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis. Clin Auton Res 2012;22:43-55. [PMID: 21792729 DOI: 10.1007/s10286-011-0135-5] [Cited by in Crossref: 70] [Cited by in F6Publishing: 55] [Article Influence: 6.4] [Reference Citation Analysis]
158 Nuvoli S, Spanu A, Piras MR, Nieddu A, Mulas A, Rocchitta G, Galleri G, Serra PA, Madeddu G. 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders. Medicine (Baltimore) 2017;96:e6967. [PMID: 28538394 DOI: 10.1097/MD.0000000000006967] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
159 Angelidis G, Giamouzis G, Karagiannis G, Butler J, Tsougos I, Valotassiou V, Giannakoulas G, Dimakopoulos N, Xanthopoulos A, Skoularigis J, Triposkiadis F, Georgoulias P. SPECT and PET in ischemic heart failure. Heart Fail Rev 2017;22:243-61. [DOI: 10.1007/s10741-017-9594-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
160 Zhang DY, Anderson AS. The sympathetic nervous system and heart failure. Cardiol Clin. 2014;32:33-45, vii. [PMID: 24286577 DOI: 10.1016/j.ccl.2013.09.010] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 7.4] [Reference Citation Analysis]
161 Ketchum ES, Jacobson AF, Caldwell JH, Senior R, Cerqueira MD, Thomas GS, Agostini D, Narula J, Levy WC. Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging. J Nucl Cardiol 2012;19:1007-16. [PMID: 22949270 DOI: 10.1007/s12350-012-9603-0] [Cited by in Crossref: 51] [Cited by in F6Publishing: 30] [Article Influence: 5.1] [Reference Citation Analysis]